A 7-month cigarette smoke inhalation study in C57BL/6 mice demonstrates reduced lung inflammation and emphysema following smoking cessation or aerosol exposure from a prototypic modified risk tobacco product.

[1]  P. Avino,et al.  Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers. , 2015, Environmental pollution.

[2]  Yang Xiang,et al.  Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models , 2014, BMC Bioinformatics.

[3]  Julia Hoeng,et al.  A 28-day rat inhalation study with an integrated molecular toxicology endpoint demonstrates reduced exposure effects for a prototypic modified risk tobacco product compared with conventional cigarettes. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[4]  Julia Hoeng,et al.  Case study: the role of mechanistic network models in systems toxicology. , 2014, Drug discovery today.

[5]  Manuel C. Peitsch,et al.  Systems Toxicology: From Basic Research to Risk Assessment , 2014, Chemical research in toxicology.

[6]  S. Bozinovski,et al.  Recent advances in pre-clinical mouse models of COPD , 2013, Clinical science.

[7]  O. Schmid,et al.  The composition of cigarette smoke determines inflammatory cell recruitment to the lung in COPD mouse models , 2013, Clinical science.

[8]  Louis G. Iasilli.  Federal Food, Drug and Cosmetic Act , 2014 .

[9]  C. von Garnier,et al.  SerpinB1 deficiency is not associated with increased susceptibility to pulmonary emphysema in mice. , 2013, American journal of physiology. Lung cellular and molecular physiology.

[10]  M. Peitsch,et al.  Cigarette smoke induces molecular responses in respiratory tissues of ApoE(-/-) mice that are progressively deactivated upon cessation. , 2013, Toxicology.

[11]  Julia Hoeng,et al.  Quantitative assessment of biological impact using transcriptomic data and mechanistic network models. , 2013, Toxicology and applied pharmacology.

[12]  E. Egecioglu,et al.  The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as well as the Expression of Locomotor Sensitization in Mice , 2013, PloS one.

[13]  Manuel C. Peitsch,et al.  Systems Approaches Evaluating the Perturbation of Xenobiotic Metabolism in Response to Cigarette Smoke Exposure in Nasal and Bronchial Tissues , 2013, BioMed research international.

[14]  Don D. Sin,et al.  Aging does not Enhance Experimental Cigarette Smoke-Induced COPD in the Mouse , 2013, PloS one.

[15]  P. Foster,et al.  A new short-term mouse model of chronic obstructive pulmonary disease identifies a role for mast cell tryptase in pathogenesis. , 2013, The Journal of allergy and clinical immunology.

[16]  Q. Hamid,et al.  T helper 17 cells in airway diseases: from laboratory bench to bedside. , 2013, Chest.

[17]  A. Kraneveld,et al.  Cigarette Smoke-Induced Collagen Destruction; Key to Chronic Neutrophilic Airway Inflammation? , 2013, PloS one.

[18]  Damian Szklarczyk,et al.  STRING v9.1: protein-protein interaction networks, with increased coverage and integration , 2012, Nucleic Acids Res..

[19]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[20]  A. Tricker,et al.  Reduced exposure evaluation of an Electrically Heated Cigarette Smoking System. Part 1: Non-clinical and clinical insights. , 2012, Regulatory toxicology and pharmacology : RTP.

[21]  Gary G. Koch,et al.  Categorical data analysis using the SAS , 2012 .

[22]  Julia Hoeng,et al.  A network-based approach to quantifying the impact of biologically active substances. , 2012, Drug discovery today.

[23]  M. R. Hayes,et al.  GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake. , 2012, Endocrinology.

[24]  Manuel C. Peitsch,et al.  Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks , 2012, BMC Systems Biology.

[25]  David Galas,et al.  Gene expression networks in COPD: microRNA and mRNA regulation , 2011, Thorax.

[26]  G. Joos,et al.  Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease , 2011 .

[27]  F. Redegeld,et al.  Mast cells and COPD. , 2011, Pulmonary pharmacology & therapeutics.

[28]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[29]  H. Haussmann,et al.  Murine lung tumor response after exposure to cigarette mainstream smoke or its particulate and gas/vapor phase fractions. , 2010, Toxicology.

[30]  Seung-Hyo Lee,et al.  Role of Th17 Cell and Autoimmunity in Chronic Obstructive Pulmonary Disease , 2010, Immune network.

[31]  A. Kraneveld,et al.  Inflammatory changes in the airways of mice caused by cigarette smoke exposure are only partially reversed after smoking cessation , 2010, Respiratory research.

[32]  D. Vecchio,et al.  Reactivity of mouse alveolar macrophages to cigarette smoke is strain dependent. , 2010, American journal of physiology. Lung cellular and molecular physiology.

[33]  M. Decramer,et al.  Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases. , 2010, American journal of respiratory cell and molecular biology.

[34]  P. Barnes,et al.  The cytokine network in chronic obstructive pulmonary disease. , 2009, American journal of respiratory cell and molecular biology.

[35]  I. Adcock,et al.  T helper type 17‐related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients , 2009, Clinical and experimental immunology.

[36]  P. Barnes,et al.  The cytokine network in asthma and chronic obstructive pulmonary disease. , 2008, The Journal of clinical investigation.

[37]  Susan E. Wrenn,et al.  Smoke chemistry, in vitro and in vivo toxicology evaluations of the electrically heated cigarette smoking system series K. , 2008, Regulatory toxicology and pharmacology : RTP.

[38]  I. Rahman,et al.  Cigarette smoke-mediated inflammatory and oxidative responses are strain-dependent in mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[39]  Takwi Nkyimbeng,et al.  Transgenic expression of matrix metalloproteinase-9 causes adult-onset emphysema in mice associated with the loss of alveolar elastin. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[40]  V. Kim,et al.  New concepts in the pathobiology of chronic obstructive pulmonary disease. , 2008, Proceedings of the American Thoracic Society.

[41]  M. Cosio,et al.  Mechanisms of cigarette smoke-induced COPD: insights from animal models. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[42]  Y. Nasuhara,et al.  Decreased Airway Expression of Vascular Endothelial Growth Factor in Cigarette Smoke-Induced Emphysema in Mice and COPD Patients , 2008, Inhalation toxicology.

[43]  Christopher S. Stevenson,et al.  Comprehensive gene expression profiling of rat lung reveals distinct acute and chronic responses to cigarette smoke inhalation. , 2007, American journal of physiology. Lung cellular and molecular physiology.

[44]  Toshinori Yoshida,et al.  Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. , 2007, Physiological reviews.

[45]  A. Churg,et al.  Animal models of cigarette smoke-induced chronic obstructive lung disease. , 2007, Contributions to microbiology.

[46]  A. Churg,et al.  Cigarette smoke drives small airway remodeling by induction of growth factors in the airway wall. , 2006, American journal of respiratory and critical care medicine.

[47]  C. Mathers,et al.  Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.

[48]  W. Arap,et al.  State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. , 2006, Proceedings of the American Thoracic Society.

[49]  R. Pauwels,et al.  Murine models of COPD. , 2006, Pulmonary pharmacology & therapeutics.

[50]  J. Friedland,et al.  Matrix metalloproteinases in destructive pulmonary pathology , 2005, Thorax.

[51]  P. Vanscheeuwijck,et al.  LUNG INFLAMMATION IN RATS FOLLOWING SUBCHRONIC EXPOSURE TO CIGARETTE MAINSTREAM SMOKE , 2006, Experimental lung research.

[52]  J. Mauderly,et al.  Life-span inhalation exposure to mainstream cigarette smoke induces lung cancer in B6C3F1 mice through genetic and epigenetic pathways. , 2005, Carcinogenesis.

[53]  S. Fineschi,et al.  Different lung responses to cigarette smoke in two strains of mice sensitive to oxidants , 2005, European Respiratory Journal.

[54]  P. Barnes.  Mediators of Chronic Obstructive Pulmonary Disease , 2004, Pharmacological Reviews.

[55]  Naftali Kaminski,et al.  Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[56]  B. Celli,et al.  Gene expression profiling of human lung tissue from smokers with severe emphysema. , 2004, American journal of respiratory cell and molecular biology.

[57]  J. Hogg,et al.  Pathophysiology of airflow limitation in chronic obstructive pulmonary disease , 2004, The Lancet.

[58]  R. Pauwels,et al.  Burden and clinical features of chronic obstructive pulmonary disease (COPD) , 2004, The Lancet.

[59]  J. Baron,et al.  Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. , 2004, Metabolism: clinical and experimental.

[60]  A. Lindén,et al.  Increased matrix metalloproteinase-9 concentration and activity after stimulation with interleukin-17 in mouse airways , 2004, Thorax.

[61]  Office on Smoking.  The Health Consequences of Smoking: A Report of the Surgeon General , 2004 .

[62]  P. Vanscheeuwijck,et al.  Toxicological evaluation of an electrically heated cigarette. Part 4: Subchronic inhalation toxicology , 2003, Journal of applied toxicology : JAT.

[63]  B. Beghé,et al.  Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPD. , 2003, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[64]  S. Gebel,et al.  Evaluation of the potential effects of ingredients added to cigarettes. Part 4: subchronic inhalation toxicity. , 2002, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[65]  S. Reddy,et al.  Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene. , 2002, American journal of respiratory cell and molecular biology.

[66]  D. Webb,et al.  Short-term effects of transdermal nicotine on acute tissue plasminogen activator release in vivo in man. , 2001, Cardiovascular Research.

[67]  R. Wallace,et al.  Clearing the Smoke , 2001 .

[68]  L. Fabbri,et al.  CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[69]  R. Zidovetzki,et al.  Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. , 1999, Stroke.

[70]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[71]  Gary G. Koch,et al.  Categorical Data Analysis Using The SAS1 System , 1995 .

[72]  K. Rustemeier,et al.  High-performance liquid chromatographic determination of nicotine and its urinary metabolites via their 1,3-diethyl-2-thiobarbituric acid derivatives. , 1993, Journal of chromatography.

[73]  A. Hayes,et al.  Ninety-day inhalation study in rats, comparing smoke from cigarettes that heat tobacco with those that burn tobacco☆ , 1989, Fundamental and Applied Toxicology.